Human PACRG(Parkin coregulated gene protein) ELISA Kit

For researchers delving into the complexities of PACRG, the Parkin Coregulated Gene Protein, our Human PACRG ELISA Kit (EH1785) is a pivotal resource. This meticulously designed kit is engineered for precise and efficient quantification of PACRG levels in human samples, ensuring data integrity and trustworthiness.
Precision and Accuracy: The EH1785 kit guarantees the highest level of precision and accuracy, ensuring that your quantification of PACRG is reliable and trustworthy. This precision is paramount for robust scientific inquiry.
Broad Detection Range: This kit accommodates a wide range of sample concentrations, making it ideal for diverse research applications related to PACRG, whether studying its role in Parkinson's disease, cilia function, or other processes.
User-Friendly Interface: The kit simplifies laboratory procedures with clear and intuitive protocols, optimizing the research process and user experience.
Efficiency in Time Management: Engineered for efficiency, EH1785 minimizes laboratory work time, ensuring the rapid generation of research results and enhancing overall research productivity.
As you explore the functions and roles of PACRG, this kit ensures that your data is reliable and provides a solid foundation for your scientific inquiries, whether they pertain to neurodegenerative diseases, cilia function, or other areas.

Product Name

Human PACRG(Parkin coregulated gene protein) ELISA Kit

Alias

PACRG ELISA Kit, Parkin coregulated gene protein ELISA Kit, Molecular chaperonin-binding protein ELISA Kit, PARK2 coregulated gene protein ELISA Kit

Detection Method

Sandwich ELISA, Double Antibody

Application

PACRG ELISA Kit allows for the in vitro quantitative determination of PACRG concentrations in serum, plasma, tissue homogenates and other biological fluids.

Size

96T

Range

0.313-20ng/ml

Sensitivity

< 0.188ng/ml

Species

Human

UniProt ID

Q96M98

Standard Curve

Storage

2-8 ℃ for 6 months

Recovery

Matrices listed below were spiked with certain level of PACRG and the recovery rates were calculated by comparing the measured value to the expected amount of PACRG in samples.

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of PACRG and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

CV(%)

Intra-Assay: CV<8%

Inter-Assay: CV<10%

Note

For Research Use Only